Directional and Polarized Lasing Action on Pb-free FASnI3 Integrated in Flexible Optical Waveguide

In this work, high-quality FASnI3 (FA, formamidinium) lead-free perovskite thin films are successfully incorporated in a flexible polyethylene terephthalate (PET) substrate to demonstrate amplified spontaneous emission (ASE) and lasing. The waveguide (WG) consists of polymethylmethacrylate(PMMA)/FASnI3 bilayer deposited on a PET substrate and is properly designed to allow single-mode propagation at the photoluminescence wavelength. This geometry optimizes the excitation of the emitting FASnI3, enhances the light−matter interaction in the semiconductor thin film, provides a preferable direction for the emitted light and allows its direct outcoupling for on-chip or fiber-optic applications. As far as the authors know, ASE and random lasing are obtained for the first time in a flexible-based WG integrating a highly efficient lead-free perovskite. The high quality of the deposited films and the optimized design of the structure result in an extremely low ASE/lasing threshold in the range of 1 µJ cm−2, which is only ten times higher than that measured in the same PMMA/FASnI3 structure deposited on a rigid substrate (Si/SiO2). More interestingly, these WGs exhibit a strong polarization anisotropy for the outcoupled ASE/lasing light with a preferable transverse electric polarization. This work is the base for the future development of ecofriendly, flexible, and efficient photonic devices.This project received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 862656 (project DROP-IT) and the European Research Council (ERC) via Consolidator Grant (724424, No-LIMIT) and by the Spanish MINECO through projects no. PID2020-120484RB-I00 and PID2019-107314RB-I00 (Stable)

Lead-free FASnI3 laser amplifiers integrated in flexible waveguides

Proceedings of the Optica Advanced Photonics Congress. Maastricht, Netherlands, 24-28 July, 2022A FASnI3 lead-free perovskite is integrated in a flexible waveguide to demonstrate Amplified Spontaneous Emission. An extremely low threshold, 1 µJ/cm2, is observed together with the formation of narrow random lasing lines (< 1 nm)

Uso de suplementos nutricionales y ayudas ergogénicas en jugadores profesionales de tenis.

Introduction: Nutritional supplements and ergogenic aids (NS&EA) are used between training/matches with the goal of enhancing tennis performance. Scientific literature about prevalence and use of NS&EA in professional tennis players is scarce. Objective: The aim of the study was to describe the NS&EA used by professional tennis players during a season. Methods: Using a validated self-administered questionnaire, 62 professional male and 9 professional female tennis players (11% in their gender specific top 100 tennis world ranking (i.e., ATP/WTA)) registered all the used NS&EA. Results: Eighty-one percent of the participants declared taking at least one NS&EA. Strength and conditioning trainers (S&C) and tennis coaches were the professionals who recommended most of the NS&EA in the players outside the TOP-100 (OT100; 50.7% and 39.1%, respectively). However, sports nutritionist were the principal advisors in the top-100 tennis players (T100; 62.5%). Sports drinks were the NS&EA most commonly used by all participants (81.7%). T100 participants used caffeine (p = 0.042), creatine (p = 0.001), iron (p = 0.013) and CHO-protein mix (p = 0.033) significantly more frequently that OT100 players. Conclusions: There is a high prevalence of NS&EA use among professional tennis players independently of their tennis ranking position. However, T100 tennis player have an increased use of certain substances such us caffeine, creatine, iron and CHO-Protein mix. For the rest of the studied NS&EA the use was similar between T100 and OT100 players. It is possible that the differences in NS&EA use between groups could be related to the different professionals on charge of nutritional advice in T100 vs OT100.Introducción: los suplementos nutricionales/ayudas ergogénicas (NS&EA) son utilizados en los entrenamientos/partidos de tenis con el objetivo de mejorar el rendimiento. Sin embargo, la literatura científica se encuentras escasos documentos científicos sobre el uso de estas sustancias en tenistas profesionales. Objetivo: describir el uso de NS&EA utilizados por tenistas profesionales durante una temporada. Métodos: se utilizó un cuestionario validado y se evaluó a 62 tenistas profesionales hombres y 9 mujeres (11% entre los 100 mejores del mundo). Resultados: el 81% de los participantes toman al menos un NS&EA. Los preparadores físicos (S&C) y entrenadores de tenis fueron los profesionales preferidos para recomendar NS&EA entre los jugadores fuera del TOP-100 (OT100, 50,7% y 39,1%, respectivamente). Sin embargo, los nutricionistas deportivos fueron los principales asesores de los jugadores entre los 100 mejores del mundo (T100, 62,5%). Las bebidas deportivas fueron los NS&EA más utilizados entre todos los participantes (81,7%). Los tenistas T100 utilizaron cafeína (p = 0,042), creatina (p = 0,001), hierro (p = 0.013) y mezcla de CHO-proteína (p = 0,033) significativamente más frecuentemente que los jugadores OT100. Conclusiones: existe una gran prevalencia de uso de NS&EA entre los tenistas profesionales. Además, los T100 presentan un mayor uso de ciertas sustancias tales como cafeína, creatina, hierro y CHO-proteína. Para el resto de los NS&EA estudiados, el uso fue similar entre los jugadores T100 y OT100. Finalmente, las diferencias en el uso de NS&EA entre grupos pudieran estar relacionadas con los diferentes profesionales escogidos para el asesoramiento nutricional en T100 vs. OT100.post-print691 K

Unusual Spectrally Reproducible and High Q-Factor Random Lasing in Polycrystalline Tin Perovskite Films

An unusual spectrally reproducible near-IR random lasing (RL) with no fluctuation of lasing peak wavelength is disclosed in polycrystalline films of formamidinium tin triiodide perovskite, which have been chemically stabilized against Sn2+ to Sn4+ oxidation. Remarkably, a quality Q-factor as high as ≈104 with an amplified spontaneous emission (ASE) threshold as low as 2 µJ cm−2 (both at 20 K) are achieved. The observed spectral reproducibility is unprecedented for semiconductor thin film RL systems and cannot be explained by the strong spatial localization of lasing modes. Instead, it is suggested that the spectral stability is a result of such an unique property of Sn-based perovskites as a large inhomogeneous broadening of the emitting centers, which is a consequence of an intrinsic structural inhomogeneity of the material. Due to this, lasing can occur simultaneously in modes that are spatially strongly overlapped, as long as the spectral separation between the modes is larger than the homogeneous linewidth of the emitting centers. The discovered mechanism of RL spectral stability in semiconductor materials, possessing inhomogeneous broadening, opens up prospects for their practical use as cheap sources of narrow laser lines.Funding for open access charge: CRUE-Universitat Jaume IThis work was supported by Horizon 2020 research and innovation program through the DROP-IT project (grant agreement No. 862656) and the Ministry of Science and Innovation of Spain under projects STABLE (PID2019-107314RB-I00) and PERIPHERAL (PID2020-120484RB-I00)

Tin perovskite solar cells with >1,300 h of operational stability in N2 through a synergistic chemical engineering approach

Despite the promising properties of tin-based halide perovskites, one clear limitation is the fast Sn+2 oxidation. Consequently, the preparation of long-lasting devices remains challenging. Here, we report a chemical engineering approach, based on adding Dipropylammonium iodide (DipI) together with a well-known reducing agent, sodium borohydride (NaBH4), aimed at preventing the premature degradation of Sn-HPs. This strategy allows for obtaining efficiencies (PCE) above 10% with enhanced stability. The initial PCE remained unchanged upon 5 h in air (60% RH) at maximum-power-point (MPP). Remarkably, 96% of the initial PCE was kept after 1,300 h at MPP in N2. To the best of our knowledge, these are the highest reported values for Sn-based solar cells. Our findings demonstrate a beneficial synergistic effect when additives are incorporated, highlight the important role of iodide in the performance upon light soaking, and, ultimately, unveil the relevance of controlling the halide chemistry for future improvement of Sn-based perovskite devices

Purcell Enhancement and Wavelength Shift of Emitted Light by CsPbI3 Perovskite Nanocrystals Coupled to Hyperbolic Metamaterials

Manipulation of the exciton emission rate in nanocrystals of lead halide perovskites (LHPs) was demonstrated by means of coupling of excitons with a hyperbolic metamaterial (HMM) consisting of alternating thin metal (Ag) and dielectric (LiF) layers. Such a coupling is found to induce an increase of the exciton radiative recombination rate by more than a factor of three due to the Purcell effect when the distance between the quantum emitter and HMM is nominally as small as 10 nm, which coincides well with the results of our theoretical analysis. Besides, an effect of the coupling-induced long wavelength shift of the exciton emission spectrum is detected and modeled. These results can be of interest for quantum information applications of single emitters on the basis of perovskite nanocrystals with high photon emission rates

Fully Inkjet-Printed Green-Emitting PEDOT:PSS/NiO/Colloidal CsPbBr3/SnO2 Perovskite Light-Emitting Diode on Rigid and Flexible Substrates

After establishing themselves as promising active materials in the field of solar cells, halide perovskites are currently being explored for fabrication of low-cost, easily processable, and highly efficient light-emitting diodes (LEDs). Despite this, the highest efficiencies reported for perovskite-based LEDs (PeLEDs) are achieved through spin coating or vacuum evaporation deposition techniques, which are not adequate, in most of the cases, for an industrial-scale production. Additionally, the long-term stability is still a big handicap, even though all inorganic perovskites, such as CsPbBr3, are found to be more stable to external variables. In this context, herein, the fabrication of fully inkjet-printed (IJP) CsPbBr3-based PeLEDs in ambient conditions, on rigid and flexible substrates, on a proof-of-concept basis, with the successful incorporation of NiO and SnO2 as hole- and electron-selective contacts, respectively, is reported. Despite the moderate luminance (324 cd m−2) value obtained, this result paves the way toward the development of upscalable fabrication of PeLEDs based on deposition techniques with controlled spatial resolution.The authors wish to thank the financial support from the European Commission via FET Open Grant (862656, DROP-IT), MINECO (Spain) for grant PID2019-105658RB-I00 (PRITES project), Ministry of Science and Innovation of Spain under Project STABLE (PID2019-107314RB-I00), and Generalitat Valenciana via Prometeo Grant Q-Devices (Prometeo/2018/098)

Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

Dravet syndrome is a genetic encephalopathy characterized by severe epilepsy combined with motor, cognitive, and behavioral abnormalities. Current antiepileptic drugs achieve only partial control of seizures and provide little benefit on the patient’s neurological development. In >80% of cases, the disease is caused by haploinsufficiency of the SCN1A gene, which encodes the alpha subunit of the Nav1.1 voltage-gated sodium channel. Novel therapies aim to restore SCN1A expression in order to address all disease manifestations. We provide evidence that a high-capacity adenoviral vector harboring the 6-kb SCN1A cDNA is feasible and able to express functional Nav1.1 in neurons. In vivo, the best biodistribution was observed after intracerebral injection in basal ganglia, cerebellum, and prefrontal cortex. SCN1A A1783V knockin mice received the vector at 5 weeks of age, when most neurological alterations were present. Animals were protected from sudden death, and the epileptic phenotype was attenuated. Improvement of motor performance and interaction with the environment was observed. In contrast, hyperactivity persisted, and the impact on cognitive tests was variable (success in novel object recognition and failure in Morris water maze tests). These results provide proof of concept for gene supplementation in Dravet syndrome and indicate new directions for improvement

Clinical relevance of timing of assessment of ICU mortality in patients with moderate-to-severe Acute Respiratory Distress Syndrome

Mortality is a frequently reported outcome in clinical studies of acute respiratory distress syndrome (ARDS). However, timing of mortality assessment has not been well characterized. We aimed to identify a crossing-point between cumulative survival and death in the intensive care unit (ICU) of patients with moderate-to-severe ARDS, beyond which the number of survivors would exceed the number of deaths. We hypothesized that this intersection would occur earlier in a successful clinical trial vs. observational studies of moderate/severe ARDS and predict treatment response. We conducted an ancillary study of 1580 patients with moderate-to-severe ARDS managed with lung-protective ventilation to assess the relevance and timing of measuring ICU mortality rates at different time-points during ICU stay. First, we analyzed 1303 patients from four multicenter, observational cohorts enrolling consecutive patients with moderate/severe ARDS. We assessed cumulative ICU survival from the time of moderate/severe ARDS diagnosis to ventilatory support discontinuation within 7-days, 28-days, 60-days, and at ICU discharge. Then, we compared these findings to those of a successful randomized trial of 277 moderate/severe ARDS patients. In the observational cohorts, ICU mortality (487/1303, 37.4%) and 28-day mortality (425/1102, 38.6%) were similar (p = 0.549). Cumulative proportion of ICU survivors and non-survivors crossed at day-7; after day-7, the number of ICU survivors was progressively higher compared to non-survivors. Measures of oxygenation, lung mechanics, and severity scores were different between survivors and non-survivors at each point-in-time (p < 0.001). In the trial cohort, the cumulative proportion of survivors and non-survivors in the treatment group crossed before day-3 after diagnosis of moderate/severe ARDS. In clinical ARDS studies, 28-day mortality closely approximates and may be used as a surrogate for ICU mortality. For patients with moderate-to-severe ARDS, ICU mortality assessment within the first week of a trial might be an early predictor of treatment response

Caffeine Ingestion Reverses the Circadian Rhythm Effects on Neuromuscular Performance in Highly Resistance-Trained Men

Purpose: To investigate whether caffeine ingestion counteracts the morning reduction in neuromuscular performance associated with the circadian rhythm pattern. Methods: Twelve highly resistance-trained men underwent a battery of neuromuscular tests under three different conditions; i) morning (10:00 a.m.) with caffeine ingestion (i.e., 3 mg kg 21; AMCAFF trial); ii) morning (10:00 a.m.) with placebo ingestion (AMPLAC trial); and iii) afternoon (18:00 p.m.) with placebo ingestion (PMPLAC trial). A randomized, doubleblind, crossover, placebo controlled experimental design was used, with all subjects serving as their own controls. The neuromuscular test battery consisted in the measurement of bar displacement velocity during free-weight full-squat (SQ) and bench press (BP) exercises against loads that elicit maximum strength (75 % 1RM load) and muscle power adaptations (1 m s 21 load). Isometric maximum voluntary contraction (MVCLEG) and isometric electrically evoked strength of the right knee (EVOK LEG) were measured to identify caffeine’s action mechanisms. Steroid hormone levels (serum testosterone, cortisol and growth hormone) were evaluated at the beginning of each trial (PRE). In addition, plasma norepinephrine (NE) and epinephrine were measured PRE and at the end of each trial following a standardized intense (85 % 1RM) 6 repetitions bout of SQ (POST). Results: In the PM PLAC trial, dynamic muscle strength and power output were significantly enhanced compared with AM PLA